Vigilare Wealth Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Vigilare Wealth Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,720	Closed	-$226K	–	130
2022 Q1	$226K	Sell	22,720 -2,950	-11%	-$31.3K	0.19%	122
2021 Q4	$302K	Buy	25,670 +2,170	+9%	+$26.7K	0.18%	137
2021 Q3	$268K	Buy	23,500 +4,700	+25%	+$61.2K	0.17%	155
2021 Q2	$262K	Buy	18,800 +7,955	+73%	+$121K	0.16%	164
2021 Q1	$201K	Buy	+10,845	New	+$222K	0.14%	183

Other funds holding KNSA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return